Vladonix
Peptide bioregulator referenced for immune/thymus support.
We have not published an audit on Vladonix. Everything below is reference material, not our own reading of the literature, treat it as a starting point for questions, not as a grade.
How it is thought to work
Tissue-specific peptide bioregulation (theoretical).
What sources report
These are figures published elsewhere, reproduced with their source. Peppersite does not recommend an amount for Vladonix or for anything else, and nothing below has been checked against the study it came from.
| Amount | Frequency | Route | Reported by |
|---|---|---|---|
| 1-2 capsules daily (commonly 2 capsules daily) | once or twice daily20-30 day course · Repeat course 1-2x per year | oral | Commonly published practitioner dosing range - provider confirmation required. |
- once or twice daily20-30 day course · Repeat course 1-2x per year
- oral
- Commonly published practitioner dosing range - provider confirmation required.
- Oral capsules (peptide bioregulator) · Not applicable (oral capsule)
The reference sections above are imported from our compound knowledge base, which classes the evidence for Vladonix as theoretical. That classification is the knowledge base’s, not ours, our own grade appears only where an audit is linked above. Research use only; nothing here is medical advice or a protocol.
5-Amino-1MQ is a small molecule studied for its potential to help the body shrink fat cells and raise NAD+ levels without cutting appetite.
AOD9604 is a modified C-terminal fragment of human growth hormone (residues 176-191), studied in lipid metabolism research models.
BPC-157 is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. Studied in tissue-repair and regeneration research models.
Peptide bioregulator referenced for connective tissue support.
Peptide bioregulator referenced for nervous system support.
Combination research blend of CJC-1295 (no DAC) and Ipamorelin. Studied as a GHRH/GHRP combination in growth-hormone-axis research.